InferRead Lung CT.AI is now FDA cleared, and has also received the CE mark in Europe. "This is the first FDA clearance for our deep-learning-based chest CT algorithm and it will lead the way to better integration of advanced A.I. solutions to help the healthcare clinical workflow in the region," according to Matt Deng. "This marks a great start in the North American market, and we are expecting to provide more high-performance AI tools in the near future."
About Infervision
Ad Statistics
Times Displayed: 174933
Times Visited: 3187 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
Infervision is committed to the clinical application of artificial intelligence and deep learning technologies in health care, providing AI-based platforms and tools fully integrated with medical workflows. Health providers in over 10 countries in Asia, Europe, North America use Infervision's highly precise and efficient clinical tools, empowering them with improved clinical insights. Infervision currently has 8 global offices and over 300 employees worldwide. Each day Infervision helps process over 55,000 exams, and accumulatively 19M case reviews since 2015. Learn more about Infervision's product suites at global.infervision.com
SOURCE Infervision North America
Back to HCB News
